Effects of Nutrition Meal Replacement and Individualized Exercise Prescription on Type 2 Diabetes
NCT02984605 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2016-12-07
Summary
This study evaluates the nutritional meal replacement and individualized exercise prescription intervention on overweight and obese type 2 diabetes mellitus. Half of participants will receive nutritional meal replacement and individualized exercise prescription on the basis of conventional glucose-lowering treatment, while the other half will only receive conventional glucose-lowering treatment.
Conditions
- Overweight
- Obesity
- Type2 Diabetes
Interventions
- DIETARY_SUPPLEMENT
-
nutritional meal replacement
1 times a day with bags of nutritional meal replacement + individualized exercise prescription
Sponsors & Collaborators
-
Shanghai University of Sports National Science Park
collaborator UNKNOWN -
Yinhang Community Health Service Center of Yangpu District
collaborator UNKNOWN -
Dinghai Community Health Service Center of Yangpu District
collaborator UNKNOWN -
Kongjiang Community Health Service Center of Yangpu District
collaborator UNKNOWN -
Daqiao Community Health Service Center of Yangpu District
collaborator UNKNOWN -
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
lead OTHER
Principal Investigators
-
Ming Cui, MD · YinXing Community Health Service Center of Yangpu District
-
Wenbin Liu, MD · Dinghai Community Health Service Center of Yangpu District
-
Xiaoyi Che, MD · Kongjiang Community Health Service Center of Yangpu District
-
Hui Liu, MD · Daqiao Community Health Service Center of Yangpu District
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-12-31
- Primary Completion
- 2018-12-31
- Completion
- 2020-12-31
More Related Trials
-
Effectiveness of Glucose Control, β Cell Function in Response to Short-term Insulin Pump Therapy in Type 2 Diabetes
NCT03509324 ·Status: COMPLETED ·Phase: PHASE4
-
Metabolic Characteristics of Lean Diabetes in Rural and Semi-urban India and in the United States
NCT02987335 ·Status: COMPLETED
-
Diabetes Intervention Accentuating Diet and Enhancing Metabolism
NCT03225339 ·Status: COMPLETED ·Phase: NA
-
A Pilot Study to Evaluate the Glucagon-Like Peptide 1 Response to the Challenge of Mixed Meals in Chinese Subjects
NCT00884091 ·Status: COMPLETED
-
Effect of Fasting Therapy on Blood Glucose Control and Islet Function in Newly Diagnosed Type 2 Diabetic Patients
NCT02956655 ·Status: UNKNOWN ·Phase: NA
-
Effect of Dulaglutide on Glycemic Variability in Patients With Type 2 Diabetes
NCT04374578 ·Status: COMPLETED
-
Study of Comparison the Treatment Effect Between Gastric Bypass and Exenatide in Type 2 Diabetes
NCT01435980 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study Comparing Degu Insulin Liraglutide Injection With Premixed Insulin on the Prognosis of Diabetes Mellitus
NCT06925334 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Efficacy Study of Liraglutide vs.Sitagliptin vs. Glargine on Liver Fat in T2DM Subjects
NCT02147925 ·Status: COMPLETED ·Phase: PHASE4
-
Combined Active Treatment in Type 2 Diabetes with NASH
NCT04639414 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Insulin Therapy in Type 2 Diabetic Patients: Real-life Study on Effectiveness and Satisfaction
NCT06117449 ·Status: NOT_YET_RECRUITING
-
Meal Frequency and Glycemic Control in Individuals With Type 1 Diabetes
NCT06934707 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Importance of Meal Composition on Preventing Exercise-induced Hypoglycemia in People With Type 1 Diabetes.
NCT04472962 ·Status: COMPLETED ·Phase: NA
-
Effects of Exercise and GLP-1 Agonism on Muscle Microvascular Perfusion and Insulin Action in Adults With Metabolic Syndrome
NCT04575844 ·Status: RECRUITING ·Phase: PHASE4
-
Effect of Exercise and/or Liraglutide on Vascular Dysfunction and Insulin Sensitivity in Type 2 Diabetes ( ZQL007)
NCT03883412 ·Status: RECRUITING ·Phase: PHASE4
-
Effects of Glucagon Like Peptide-1 on No-reflow
NCT02507128 ·Status: UNKNOWN ·Phase: NA
-
Clinical Study of Umbilical Cord Mesenchymal Stem Cells in the Treatment of Type 2 Diabetic Nephropathy
NCT04216849 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Effects of Short-term Intensive Insulin Therapy on Long-term Complications in Type 2 Diabetes
NCT03909555 ·Status: UNKNOWN
-
The Impact of Semaglutide Compared to Energy Restriction on Type 2 Diabetes
NCT07272343 ·Status: RECRUITING ·Phase: PHASE4
-
The Effect of Gastric Emptying on Blood Glucose Profile of Type 1 Diabetes Mellitus and Its Therapeutic Strategies
NCT06173934 ·Status: RECRUITING ·Phase: NA
-
Effect of Medically-tailored Meal Delivery Service on Changes in Hemoglobin A1c (HbA1c) in Patients With Diabetes
NCT04523155 ·Status: COMPLETED ·Phase: NA
-
Effects of a Small Protein and Lipid Preload on Glucose Tolerance in Subjects With Impaired Glucose Homeostasis
NCT02342834 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Intermediate Care Clinics for Diabetes
NCT00945204 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Integrated Radio Frequency Denervation System to Improve Glycemic Control in Type 2 Diabetic Subjects
NCT04285554 ·Status: COMPLETED ·Phase: NA
-
Effects of Metformin Treatment on Myocardial Efficiency in Patients With Heart Failure
NCT02810132 ·Status: COMPLETED ·Phase: PHASE2